NewsBite

Proteomics International Laboratories

Advertisement
Proteomics International Laboratories has opened a new laboratory in the United States, certified by the State of California, to roll out its novel PromarkerD kidney disease test.

New Proteomics US testing lab opens door to vast diagnostic market

Proteomics International Laboratories can roll out its novel diabetes-related blood test in the US, having received certification for its Californian reference lab.

  • James Pearson

Latest

OxiDx, a majority-owned subsidiary of biotech company Proteomics International, has revealed a simple fingerprick test to detect and monitor muscle damage in elite athletes.

Proteomics world-first blood test tracks muscle recovery in athletes

A Proteomics International subsidiary has unveiled a novel fingerprick test to track muscle damage in elite runners, transforming recovery and performance management in athletes.

  • James Pearson
Proteomics International’s game-changing PromarkerEndo diagnostic blood test for endometriosis has passed its latest clinical trials with flying colours.

Proteomics nails near perfect results for endometriosis blood test

Proteomics International soared 24pc to 75c on news its PromarkerEndo test could successfully diagnose all stages of endometriosis, which affects 10pc of women.

  • James Pearson
Proteomics has revealed high levels of accuracy for its simple “PromarkerEso” blood test that is used to detect esophageal cancer.

Proteomics lands blow on deadly esophageal cancer

Proteomics International Laboratories has boosted its fight against a deadly form of cancer after its blood test showed a detection accuracy of 94 per cent.

  • Bart Bogacz
Dr James Williams, a biotech industry veteran, has been appointed to the board of Proteomics International Laboratories as a non-executive director.

Proteomics adds biotech stalwart to boost diagnostics growth

Proteomics International Laboratories has hired industry veteran Dr James Williams to help guide it towards commercialising its predictive diagnostics tools.

  • James Pearson
Proteomics International Laboratories’ PromarkerD test has shown to be highly accurate in predicting future kidney disease in type 1 diabetes patients.

Proteomics testing pinpoints future kidney disease risks

Proteomics International Laboratories’ “PromarkerD” testing has shown a high accuracy in predicting future kidney disease in type 1 diabetes patients.

  • James Pearson

Original URL: https://www.theage.com.au/topic/piq-18o